Nasdaq Biotechnology Ishares (IBB) 215.45 $IBB
Stocks Revisit Session Lows; Share Offer Lifts GasLog
at Investor's Business Daily - Fri Apr 11, 2:03PM CDT
Selling picked up pace Friday afternoon as Wall Street weighed earnings reports in the financial sector and a better-than-expected reading on consumer confidence. The Nasdaq slumped 1.1%. The Dow Jones industrial average and S&P 500 each fell 0.8%....
Jim Cramer's Mad Dash: HRB GILD
at The Street - Fri Apr 11, 9:38AM CDT
The tax man cometh and shows no sign of leaving, which means good news for H&R Block as it spins off its banking division, Cramer says.
Inside the Wild Ride of Biotech ETFs - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Apr 11, 9:01AM CDT
Biotech ETFs have been crashing, but have all the funds been performing the same in the space?
Today's Biotech Stocks to Watch: AbbVie Inc., Enanta Pharmaceuticals Inc. and Gilead Sciences
George Budwell, The Motley Fool - Motley Fool - Fri Apr 11, 7:57AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for AbbVie , Enanta Pharmaceuticals and Gilead Sciences AbbVie and Enanta presented additional data from two late-stage studies dubbed SAPPHIRE-I and...
Stock Market Volatility: Here's What's Happening
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Fri Apr 11, 7:40AM CDT
After two consecutive winning days brought U.S. stocks back to within 1% of their all-time high, the major indexes suffered bruising losses on Thursday, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average losing 2.1% and...
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 5.61% Sell Off
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
iShares Nasdaq Biotechnology Index Falls 5.61% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Oh Biotech, You Are a Cruel Bitch
at The Street - Thu Apr 10, 12:09PM CDT
Wednesday's mini rally was a head fake, leading to more selling Thursday.
A Small-Cap Biotech Stock on the Verge of a Breakout
at The Street - Wed Apr 09, 1:58PM CDT
This small-cap biotech stock should be on your trading radar.
'Fast Money' Recap: S&P Snapback
at The Street - Wed Apr 09, 4:00AM CDT
The trading panel discussed whether investors can trust this latest rlly.
Shares of IBB Down 11.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Apr 07, 10:01AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 4 weeks, iShares Nasdaq Biotechnology Index has returned 11.33% as of today's recent price of $228.98.
Is Biotech in a Bubble? The Bear Case Explained
Chris Ahlstrand, The Motley Fool - Motley Fool - Fri Apr 04, 8:30AM CDT
The rumblings of a biotech bubble are getting louder as the Nasdaq Biotech Index has declined about 14% from its peak of $275.40 on February 25th. The recent volatility is a phenomenon that has not been seen in quite some time in the space. So is...
3 Biggest Biotech Crashes in March
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but the drop in some biotech stocks was simply breathtaking . Celldex Therapeutics , Acceleron , and Newlink Genetics all tumbled more than 25% last month -- far more than the 10% drop in the ...
3 Stocks That Escaped Biotech's March Madness
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but there were a few biotech stocks that soared. Among them were Agios Pharmaceuticals , Chimerix, Inc. , and Portola Pharmaceuticals . All three shrugged off the broad biotech sell-off that...
Can ANI Pharmaceuticals, Inc. Beat the Biotech Bubble?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 02, 8:30AM CDT
After last Friday's volatile session, biotechs are now barely in the green for the year, having given back nearly all of their gains. Specifically, the iShares Biotechnology Index had been up over 20% earlier this year, but it can now only lay...
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.22% Gain
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.22% Yesterday
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Any Survivors from the Biotech ETF Meltdown? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 3:00PM CDT
Although all biotech ETFs crumbled last week, many might still be well positioned for the future.
Stocks Revisit Session Lows; Share Offer Lifts GasLog
at Investor's Business Daily - Fri Apr 11, 2:03PM CDT
Selling picked up pace Friday afternoon as Wall Street weighed earnings reports in the financial sector and a better-than-expected reading on consumer confidence. The Nasdaq slumped 1.1%. The Dow Jones industrial average and S&P 500 each fell 0.8%....
Jim Cramer's Mad Dash: HRB GILD
at The Street - Fri Apr 11, 9:38AM CDT
The tax man cometh and shows no sign of leaving, which means good news for H&R Block as it spins off its banking division, Cramer says.
Inside the Wild Ride of Biotech ETFs - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Apr 11, 9:01AM CDT
Biotech ETFs have been crashing, but have all the funds been performing the same in the space?
Today's Biotech Stocks to Watch: AbbVie Inc., Enanta Pharmaceuticals Inc. and Gilead Sciences
George Budwell, The Motley Fool - Motley Fool - Fri Apr 11, 7:57AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for AbbVie , Enanta Pharmaceuticals and Gilead Sciences AbbVie and Enanta presented additional data from two late-stage studies dubbed SAPPHIRE-I and...
Stock Market Volatility: Here's What's Happening
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Fri Apr 11, 7:40AM CDT
After two consecutive winning days brought U.S. stocks back to within 1% of their all-time high, the major indexes suffered bruising losses on Thursday, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average losing 2.1% and...
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 5.61% Sell Off
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
iShares Nasdaq Biotechnology Index Falls 5.61% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Apr 10, 3:48PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $219.69 to a high of $234.57. Yesterday, the shares fell 5.6%, which took the trading range below the 3-day low of $221.18 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Oh Biotech, You Are a Cruel Bitch
at The Street - Thu Apr 10, 12:09PM CDT
Wednesday's mini rally was a head fake, leading to more selling Thursday.
A Small-Cap Biotech Stock on the Verge of a Breakout
at The Street - Wed Apr 09, 1:58PM CDT
This small-cap biotech stock should be on your trading radar.
'Fast Money' Recap: S&P Snapback
at The Street - Wed Apr 09, 4:00AM CDT
The trading panel discussed whether investors can trust this latest rlly.
Shares of IBB Down 11.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Apr 07, 10:01AM CDT
SmarTrend identified a Downtrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on March 10th, 2014 at $258.23. In approximately 4 weeks, iShares Nasdaq Biotechnology Index has returned 11.33% as of today's recent price of $228.98.
Is Biotech in a Bubble? The Bear Case Explained
Chris Ahlstrand, The Motley Fool - Motley Fool - Fri Apr 04, 8:30AM CDT
The rumblings of a biotech bubble are getting louder as the Nasdaq Biotech Index has declined about 14% from its peak of $275.40 on February 25th. The recent volatility is a phenomenon that has not been seen in quite some time in the space. So is...
3 Biggest Biotech Crashes in March
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but the drop in some biotech stocks was simply breathtaking . Celldex Therapeutics , Acceleron , and Newlink Genetics all tumbled more than 25% last month -- far more than the 10% drop in the ...
3 Stocks That Escaped Biotech's March Madness
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 5:30PM CDT
March was pretty rough for the biotech sector, but there were a few biotech stocks that soared. Among them were Agios Pharmaceuticals , Chimerix, Inc. , and Portola Pharmaceuticals . All three shrugged off the broad biotech sell-off that...
Can ANI Pharmaceuticals, Inc. Beat the Biotech Bubble?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 02, 8:30AM CDT
After last Friday's volatile session, biotechs are now barely in the green for the year, having given back nearly all of their gains. Specifically, the iShares Biotechnology Index had been up over 20% earlier this year, but it can now only lay...
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.22% Gain
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.22% Yesterday
Comtex SmarTrend(R) - Tue Apr 01, 3:54PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $237.98 to a high of $244.61. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $238.73 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Any Survivors from the Biotech ETF Meltdown? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 3:00PM CDT
Although all biotech ETFs crumbled last week, many might still be well positioned for the future.
